<DOC>
	<DOCNO>NCT02943161</DOCNO>
	<brief_summary>This study evaluate whether treatment L-citrulline , amino acid find food , increase level L-arginine thereby restore concentration nitric oxide ( NO ) airways .</brief_summary>
	<brief_title>Asthma L-Citrulline Pilot Study</brief_title>
	<detailed_description>Research show obese asthmatic metabolic imbalance L-arginine level reduce . L-arginine amino acid use make NO , gas normally make bronchi ensures lung function properly . In pilot study subject asthma increase body mass index compatible obese , invited participate short open-label treatment 15g/day L-citrulline two week . Study participant ask lung function test donate blood take supplement . L-citrulline safe well tolerate use much high dos without significant side effect .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Adequate completion inform consent process write documentation Male female patient , 18 60 year old , inclusive Physician diagnosis asthma ( medical record , ICD 10 cod physician 's diagnosis ) Confirmation asthma : Either ( 1 ) 12 % great bronchodilator response ( BDR ) FEV1 4 puff albuterol visit 1 historical BDR PC20 methacholine ≤ 16 mg/ml . Historical result previous study document clinical record within precede year acceptable alternative All racial/ethnic background may participate BMI ≥ 30 Regular treatment low medium dose ICS ICS/LABA combination medication ( please refer Inhaled Corticosteriod Doses Asthma Table ) Smoking history &lt; 10 pack year smoke last year V1 eNO ≤ 25ppb Respiratory tract infection within 4 week prior study ( may reenroll 4 week ) . Oral systemic corticosteroid burst ( indication ) within 4 week Onetime dos , intraarticular injection shoulder knee joint , require 2week washout . Asthmarelated ER visit within previous 4 week Visit 0 Significant concomitant medical illness , include ( limited ) Heart disease Cancer Uncontrolled diabetes , Chronic renal failure ( estimate GFR &lt; 30 ml/minute ) Visit 0 ( Associated high ADMA level ) Untreated sleep apnea Other chronic lung/respiratory disease ( COPD , IBF , etc . ) High dose inhale steroid ( &gt; 500 mcg/day Fluticasone equivalent ) Current statin use ( statin low ADMA level ) ; patient may stop statin approval primary physician enroll 6week washout Positive urine pregnancy test Visit 0 time study Intolerance allergy Larginine Lcitrulline Concomitant use PDE5 drug oral mononitrates Participation intervention study ( include nonpharmacologic intervention ) use investigative drug within past 30 day plan enroll trial study Unable unlikely complete study assessment opinion Investigator Study intervention pose undue risk patient opinion Investigator Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>L-citrulline</keyword>
</DOC>